Elsevier Inc.

SHERPA: Unknown

People

  1. Gucalp
    Gucalp
  2. Traina
    Traina
  3. Hudis
    Hudis
  4. Powell
    Powell
  5. Bromberg
    Bromberg
  6. Dang
    Dang
  7. Iyengar
    Iyengar
  8. Das
    Das
  9. Drullinsky
    Drullinsky
  10. Eng
    Eng

Groups

  1. Breast Medicine Service (8)
  2. Department of Medicine (8)
  3. Solid Tumor Oncology Division (8)
  4. Survivorship Research (8)
  5. GSK Faculty (5)
  6. Population Sciences Research Program (5)
  7. Biostatistics Service (4)
  8. Epidemiology and Biostatistics (4)
  9. Radiation Oncology, Department of (4)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
Search Within
  1. "Ayca Gucalp"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (2)
Groups
  1. Breast Medicine Service (8)
  2. Department of Medicine (8)
  3. Solid Tumor Oncology Division (8)
  4. Survivorship Research (8)
  5. GSK Faculty (5)
  6. Population Sciences Research Program (5)

More Groups

People
  1. Ayca Gucalp (8)
  2. Tiffany Traina (5)
  3. Clifford Hudis (4)
  4. Simon Powell (4)
  5. Chau Dang (3)
  6. Jacqueline Bromberg (3)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (1)
  6. 2014 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. Breast (1)
  3. Clinical Breast Cancer (1)
  4. European Journal of Cancer (1)
  5. Seminars in Oncology (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Quantifying the incidence of homologous recombination repair status in metastatic triple negative breast cancer receiving concurrent cisplatin and radiation therapy
    Meeting Abstract

    Powell, S. N.; Gucalp, A.; Traina, T. A.; Patil, S.; Wilgucki, M.; Arnold, B. B.; Cahlon, O.; Delsite, R.; Ulaner, G. A.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression
    Journal Article

    Gucalp, A.; Iyengar, N. M.; Hudis, C. A.; Dannenberg, A. J.
    Seminars in Oncology (2016)

    Fulltext@MSK | Save
  • Metabolic syndrome and statin use are associated with pro-estrogenic breast inflammation
    Meeting Abstract

    Iyengar, N. M.; Gucalp, A.; Zhou, X. K.; Morris, P. G.; Giri, D.; Subbaramaiah, K.; Pollak, M.; Morrow, M.; Hudis, C.; Dannenberg, A. J.
    Breast (2015)

    Fulltext@MSK | Save
  • Validating the link between obesity and breast inflammation in women with breast cancer
    Meeting Abstract

    Iyengar, N. M.; Morris, P. G.; Zhou, X. K.; Giri, D.; Harbus, M.; Falcone, D. J.; Gucalp, A.; Morrow, M.; Hudis, C. A.; Dannenberg, A. J.
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Intact RB1 pathway is associated with favorable distant metastasis-free survival in triple negative breast cancer
    Meeting Abstract

    Gupta, G. P.; Wen, Y. H.; Rogers, K.; Akram, M.; Gucalp, A.; Traina, T.; Powell, S. N.; Brogi, E.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Sparano, J. A.; Caravelli, J.; Santamauro, J.; Patil, S.; Abbruzzi, A.; Pellegrino, C.; Bromberg, J.; Dang, C.; Theodoulou, M.; more...
    Clinical Breast Cancer (2011)

    Fulltext@MSK | Save